Cargando…
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
Interleukin 1 (IL-1) is an endogenously produced cytokine that mediates a variety of physiological effects that may be beneficial or deleterious to the host. C57Bl/6 mice treated intravenously with a recently characterized human recombinant receptor antagonist protein to IL-1 (IL-1ra) had improved s...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190820/ https://www.ncbi.nlm.nih.gov/pubmed/1826127 |
Ejemplares similares
-
Interleukin 10 protects mice from lethal endotoxemia
Publicado: (1993) -
Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia
por: Gao, Daniel, et al.
Publicado: (2023) -
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
Publicado: (1993) -
Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor
Publicado: (1992) -
The Study of the Inhibition of the Recombinant TACE Prodomain to Endotoxemia in Mice
por: Li, Xiaoou, et al.
Publicado: (2009)